Table 1.
Patient characteristics
| N | % | ||
|---|---|---|---|
| Age |
Median |
50 (range, 40 – 70) |
|
| Gender |
Male |
28 |
80 |
| |
Female |
7 |
20 |
| ECOG |
1 |
18 |
51.4 |
| |
2 |
17 |
48.6 |
| Etiology |
Hepatitis B virus |
27 |
77.1 |
| |
Hepatitis C virus |
3 |
8.6 |
| |
Alcoholic |
2 |
5.7 |
| |
Other |
3 |
8.6 |
| Child-Pugh classification |
A |
28 |
80 |
| |
B |
7 |
20 |
| JIS score |
2 |
26 |
74.3 |
| |
3 |
9 |
25.7 |
| Pretreatment AFP (ng/ml) |
≤ 20 |
10 |
28.6 |
| |
> 20 |
25 |
71.4 |
| Type of HCC |
Nodular |
20 |
57.1 |
| |
Diffuse infiltrative |
15 |
42.9 |
| Multiplicity |
Solitary |
24 |
68.6 |
| |
Multiple |
11 |
31.4 |
| Location of thrombi |
PV branch |
17 |
48.6 |
| |
Main portal trunk |
18 |
51.4 |
| Previous treatment |
TACE |
30 |
85.7 |
| |
PEI and HIFU |
1 |
2.9 |
| None | 4 | 11.4 |
Abbreviations: ECOG, Eastern Cooperative Oncology Group; JIS, Japan integrated staging; AFP, α-fetoprotein; HCC, Hepatocellular carcinoma; PV, Portal vein; TACE, Transarterial chemoembolization; PEI, Percutaneous ethanol injection; HIFU, High intensity focused ultrasound.